These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 9760579)
1. Cross-presentation of self antigens to CD8+ T cells: the balance between tolerance and autoimmunity. Kurts C; Heath WR; Carbone FR; Kosaka H; Miller JF Novartis Found Symp; 1998; 215():172-81; discussion 181-90. PubMed ID: 9760579 [TBL] [Abstract][Full Text] [Related]
2. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. Kurts C; Kosaka H; Carbone FR; Miller JF; Heath WR J Exp Med; 1997 Jul; 186(2):239-45. PubMed ID: 9221753 [TBL] [Abstract][Full Text] [Related]
3. CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. Kurts C; Carbone FR; Barnden M; Blanas E; Allison J; Heath WR; Miller JF J Exp Med; 1997 Dec; 186(12):2057-62. PubMed ID: 9396776 [TBL] [Abstract][Full Text] [Related]
4. PTPN2 restrains CD8⁺ T cell responses after antigen cross-presentation for the maintenance of peripheral tolerance in mice. Wiede F; Ziegler A; Zehn D; Tiganis T J Autoimmun; 2014 Sep; 53():105-14. PubMed ID: 24997008 [TBL] [Abstract][Full Text] [Related]
5. Induction of peripheral CD8+ T-cell tolerance by cross-presentation of self antigens. Miller JF; Kurts C; Allison J; Kosaka H; Carbone F; Heath WR Immunol Rev; 1998 Oct; 165():267-77. PubMed ID: 9850866 [TBL] [Abstract][Full Text] [Related]
6. The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). Kurts C; Heath WR; Kosaka H; Miller JF; Carbone FR J Exp Med; 1998 Jul; 188(2):415-20. PubMed ID: 9670055 [TBL] [Abstract][Full Text] [Related]
7. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes. Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194 [TBL] [Abstract][Full Text] [Related]
8. Constitutive class I-restricted exogenous presentation of self antigens in vivo. Kurts C; Heath WR; Carbone FR; Allison J; Miller JF; Kosaka H J Exp Med; 1996 Sep; 184(3):923-30. PubMed ID: 9064352 [TBL] [Abstract][Full Text] [Related]
9. Kidney protection against autoreactive CD8(+) T cells distinct from immunoprivilege and sequestration. Kurts C; Klebba I; Davey GM; Koch KM; Miller JF; Heath WR; Floege J Kidney Int; 2001 Aug; 60(2):664-71. PubMed ID: 11473649 [TBL] [Abstract][Full Text] [Related]
10. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105 [TBL] [Abstract][Full Text] [Related]
11. The use of mouse models to better understand mechanisms of autoimmunity and tolerance. Miyagawa F; Gutermuth J; Zhang H; Katz SI J Autoimmun; 2010 Nov; 35(3):192-8. PubMed ID: 20655706 [TBL] [Abstract][Full Text] [Related]
12. Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by Bim. Davey GM; Kurts C; Miller JF; Bouillet P; Strasser A; Brooks AG; Carbone FR; Heath WR J Exp Med; 2002 Oct; 196(7):947-55. PubMed ID: 12370256 [TBL] [Abstract][Full Text] [Related]